JPH07291989A - Hydroquinonehydroxyalkyl ether glycoside - Google Patents

Hydroquinonehydroxyalkyl ether glycoside

Info

Publication number
JPH07291989A
JPH07291989A JP11046794A JP11046794A JPH07291989A JP H07291989 A JPH07291989 A JP H07291989A JP 11046794 A JP11046794 A JP 11046794A JP 11046794 A JP11046794 A JP 11046794A JP H07291989 A JPH07291989 A JP H07291989A
Authority
JP
Japan
Prior art keywords
glycoside
hydroquinonehydroxyalkyl
hydroquinone
ether
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP11046794A
Other languages
Japanese (ja)
Inventor
Satoru Shinojima
哲 篠島
Masaru Suetsugu
勝 末継
Yuki Shibata
由記 芝田
Rumiko Kako
留美子 加来
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP11046794A priority Critical patent/JPH07291989A/en
Publication of JPH07291989A publication Critical patent/JPH07291989A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain the novel compound glycoside being a specific hydroquinonehydroxyalkyl ether glycoside, having excellent skin-beautifying effect, free from sensitizing property and useful as a skin external preparation for cosmetics, medicines, etc. CONSTITUTION:A novel hydroquinonehydroxyalkyl ether glycoside expressed by the formula I [G1c is a group expressed by the formula II; R1 and R2 are each H, OH, a 1-10C alkyl or a hydroxyalkyl; (n) is an integer of 0-10], having excellent skin beautifying effect, free from sensitizing property and useful as an active ingredient for skin external preparation for cosmetics, medicines, etc. [e.g., 4-beta-D-glucopyranosyloxy-l-(4-hydroxyphenoxy)butane[. This compound is obtained by glycosylating hydroquinonehydroxyalkyl ether prepared by reacting hydroquinone with a halohydrin, an alkylepoxide, etc., using a glycosylating agent such as an acetylated sugar or halogenated sugar.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は皮膚美白効果を有する新
規なハイドロキノンヒドロキシアルキルエーテルの配糖
体に関する。
TECHNICAL FIELD The present invention relates to a novel hydroquinone hydroxyalkyl ether glycoside having a skin whitening effect.

【0002】[0002]

【従来の技術】皮膚のしみなどの発生機序については一
部不明な点もあるが、一般には、ホルモンの異常や日光
からの紫外線の刺激が原因となってメラニン色素が形成
され、これが皮膚内に異常沈着するものと考えられてい
る。この様なしみやあざの治療法にはメラニンの生成を
抑制する物質、例えば、ビタミンCを大量に投与する方
法、グルタチオン等を注射する方法あるいはコウジ酸、
システイン等を軟膏、クリーム、ローションなどの形態
にして、局所に塗布するなどの方法がとられている。ま
た、欧米ではハイドロキノン製剤が医薬品として用いら
れている。
BACKGROUND OF THE INVENTION Although there are some unclear points about the mechanism of skin spots and the like, in general, melanin pigments are formed due to hormonal abnormalities and irritation of ultraviolet rays from the sun, and this is the skin. It is thought to be abnormally deposited inside. Such treatments for blemishes and bruises include substances that suppress the production of melanin, for example, a method of administering a large amount of vitamin C, a method of injecting glutathione or the like, or kojic acid,
Methods such as topical application of cysteine or the like in the form of an ointment, cream, lotion or the like are used. In Europe and America, hydroquinone preparations are used as medicines.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、これら
の化合物はハイドロキノンを除いてはその効果の発現が
きわめて緩慢であるため、美白効果が十分でなく、一方
ハイドロキノンは効果は一応認められているが、感作性
があるため一般には使用が制限されている。
However, these compounds, except for hydroquinone, show a very slow effect, so that the whitening effect is not sufficient, while hydroquinone has been confirmed to have an effect. Due to its sensitizing properties, its use is generally restricted.

【0004】このような事情に鑑み、本発明者らは鋭意
研究を重ねた結果、新規なハイドロキノンヒドロキシア
ルキルエーテルの配糖体がハイドロキノン以上に美白効
果を発揮することを認め、本発明を完成するに至った。
In view of such circumstances, the inventors of the present invention have conducted extensive studies and, as a result, have found that the novel hydroquinone hydroxyalkyl ether glycoside exerts a whitening effect more than hydroquinone, and completes the present invention. Came to.

【0005】[0005]

【課題を解決するための手段】すなわち、本発明の請求
項1は下記一般式化4で表されるハイドロキノンヒドロ
キシアルキルエーテルの配糖体である。また、請求項2
は、ハイドロキノンヒドロキシアルキルエーテル配糖体
が、下記一般式化5で表されるハイドロキノンヒドロキ
シアルキルエーテル配糖体であることを特徴とする請求
項1記載のハイドロキノンヒドロキシアルキルエーテル
配糖体である。請求項3は、ハイドロキノンヒドロキシ
アルキルエーテル配糖体が、下記一般式化6で表される
ハイドロキノンヒドロキシアルキルエーテル配糖体であ
ることを特徴とする請求項1記載のハイドロキノンヒド
ロキシアルキルエーテル配糖体である。
That is, claim 1 of the present invention is a glycoside of hydroquinone hydroxyalkyl ether represented by the following general formula (4). In addition, claim 2
Is a hydroquinone hydroxyalkyl ether glycoside, which is a hydroquinone hydroxyalkyl ether glycoside represented by the following general formula 5. The hydroquinone hydroxyalkyl ether glycoside according to claim 1, wherein Claim 3 is a hydroquinone hydroxyalkyl ether glycoside, wherein the hydroquinone hydroxyalkyl ether glycoside is a hydroquinone hydroxyalkyl ether glycoside represented by the following general formula 6. is there.

【0006】[0006]

【化4】 [Chemical 4]

【0007】[0007]

【化5】 [Chemical 5]

【0008】[0008]

【化6】 [Chemical 6]

【0009】以下、本発明の構成について詳述する。本
発明に係るハイドロキノンヒドロキシアルキルエーテル
の配糖体は新規化合物であり、例えば、次の方法により
合成することができる。
The structure of the present invention will be described in detail below. The glycoside of hydroquinone hydroxyalkyl ether according to the present invention is a novel compound and can be synthesized, for example, by the following method.

【0010】すなわちハイドロキノンにハロヒドリン、
アルキルエポキシドを反応させることによりハイドロキ
ノンヒドロキシアルキルエーテルが製造される。反応は
反応に関与しない溶媒、例えば、ジメチルスルホキシ
ド、水の溶媒中で、6〜20時間、80°C〜120°
Cで反応させるのが好ましい。その後、引き続き適当な
配糖化剤、例えばアセチル化糖、ハロゲン化糖を用いて
配糖化を行うことにより、ハイドロキノンヒドロキシア
ルキルエーテルの配糖体が製造される。ここで、ハイド
ロキノンの一方のフェノール性水酸基を適当な保護基、
例えば、ベンジル基等によって保護しておき、配糖化後
に該保護基を接触還元等により脱離してもよい。また、
グルコースの水酸基を適当な保護基、例えば、アセチル
基等によって保護しておき、配糖化後に該保護基を加水
分解等により脱離してもよい。
That is, halohydrin is added to hydroquinone,
Hydroquinone hydroxyalkyl ether is produced by reacting with an alkyl epoxide. The reaction is performed in a solvent that does not participate in the reaction, for example, a solvent of dimethyl sulfoxide or water, for 6 to 20 hours at 80 ° C to 120 ° C.
It is preferable to react at C. Then, a glycoside of hydroquinone hydroxyalkyl ether is produced by subsequently performing glycosylation using an appropriate glycoside, such as acetylated sugar and halogenated sugar. Here, one of the phenolic hydroxyl groups of hydroquinone is a suitable protecting group,
For example, it may be protected with a benzyl group or the like, and after glycosylation, the protective group may be eliminated by catalytic reduction or the like. Also,
The hydroxyl group of glucose may be protected by a suitable protecting group such as an acetyl group, and the protecting group may be removed by hydrolysis after glycosylation.

【0011】具体的に物質名を例示すれば、4−β−D
−グルコピラノシルオキシ−1−(4−ヒドロキシフェ
ノキシ)ブタン、5−β−D−グルコピラノシルオキシ
−1−(4−ヒドロキシフェノキシ)ペンタン、6−β
−D−グルコピラノシルオキシ−1−(4−ヒドロキシ
フェノキシ)ヘキサン、2−β−D−グルコピラノシル
オキシ−1−(4−ヒドロキシフェノキシ)プロパン、
2−β−D−グルコピラノシルオキシ−1−(4−ヒド
ロキシフェノキシ)ブタン、2−β−D−グルコピラノ
シルオキシ−1−(4−ヒドロキシフェノキシ)プロパ
ン−3−オール等が挙げられる。
Specific examples of substance names include 4-β-D
-Glucopyranosyloxy-1- (4-hydroxyphenoxy) butane, 5-β-D-glucopyranosyloxy-1- (4-hydroxyphenoxy) pentane, 6-β
-D-glucopyranosyloxy-1- (4-hydroxyphenoxy) hexane, 2-β-D-glucopyranosyloxy-1- (4-hydroxyphenoxy) propane,
2-β-D-glucopyranosyloxy-1- (4-hydroxyphenoxy) butane, 2-β-D-glucopyranosyloxy-1- (4-hydroxyphenoxy) propan-3-ol and the like can be mentioned. To be

【0012】本発明のハイドロキノンヒドロキシアルキ
ルエーテルの配糖体を化粧品や医薬品等の外用剤に用い
る場合の配合量は外用剤全量中0.001 〜20重量%、好ま
しくは0.01〜7重量%である。0.001 重量%未満では皮
膚美白効果に乏しく、20重量%を超えて配合しても効果
の増加は望めない。
When the glycoside of the hydroquinone hydroxyalkyl ether of the present invention is used as an external preparation such as cosmetics and pharmaceuticals, the compounding amount is 0.001 to 20% by weight, preferably 0.01 to 7% by weight based on the total amount of the external preparation. If it is less than 0.001% by weight, the skin whitening effect is poor, and if it exceeds 20% by weight, the effect cannot be expected to increase.

【0013】本発明の皮膚外用剤には上記した必須構成
成分の他に通常化粧品や医薬品等の皮膚外用剤に用いら
れる他の成分、例えば、油分、紫外線吸収剤、酸化防止
剤、界面活性剤、保湿剤、香料、水、アルコール、増粘
剤、色材、皮膚栄養剤(酢酸トコフェロール、パントテ
ニールエチルエーテル、グリチルリチン酸塩)等を必要
に応じて適宜配合することができる。
The external preparation for skin of the present invention contains, in addition to the above-mentioned essential constituents, other components usually used in external preparations for skin such as cosmetics and pharmaceuticals, for example, oils, ultraviolet absorbers, antioxidants and surfactants. , Moisturizers, fragrances, water, alcohols, thickeners, coloring materials, skin nutrients (tocopherol acetate, pantotenyl ethyl ether, glycyrrhizinate) and the like can be appropriately added as necessary.

【0014】[0014]

【実施例】次に実施例をあげて本発明をさらに詳しく説
明する。本発明はこれによって限定されるものではな
い。先ず、本発明に係るハイドロキノンヒドロキシアル
キルエーテルの配糖体の合成例について詳述する。
EXAMPLES Next, the present invention will be described in more detail with reference to examples. The present invention is not limited to this. First, a synthesis example of a hydroquinone hydroxyalkyl ether glycoside according to the present invention will be described in detail.

【0015】合成例1 1−(4−ベンジルオキシフ
ェノキシ)プロパン−2−オール ハイドロキノンベンジルエーテル(10g,50mmol)をジメ
チルスルホキシド100ml ピリジン10mlに溶解させ、反応
液を120 °Cに保ち、1,2−エポキシプロパン (7ml,
0.1mol)のジメチルスルホキシド溶液100ml を滴下し
た。滴下終了後、120 °Cのまま20時間攪拌した。反応
液を減圧濃縮させ、シリカゲルカラムにて分離精製し、
1−(4−ベンジルオキシフェノキシ)プロパン−2−
オール(8.7g,収率68%)をラセミ体として得た。 融点 104.2〜105.0 °C
Synthesis Example 1 1- (4-Benzyloxyphenoxy) propan-2-ol Hydroquinone benzyl ether (10 g, 50 mmol) was dissolved in 100 ml of dimethyl sulfoxide and 10 ml of pyridine, and the reaction solution was kept at 120 ° C. -Epoxy propane (7 ml,
100 ml of a 0.1 mol) solution of dimethyl sulfoxide was added dropwise. After the completion of dropping, the mixture was stirred at 120 ° C for 20 hours. The reaction solution is concentrated under reduced pressure, separated and purified by a silica gel column,
1- (4-benzyloxyphenoxy) propane-2-
All (8.7 g, yield 68%) was obtained as a racemate. Melting point 104.2-105.0 ° C

【0016】合成例2 1−(4−ベンジルオキシフ
ェノキシ)−2−(2,3,4,6−テトラ−O−アセ
チル−β−D−グルコピラノシルオキシ)プロパン 1−(4−ベンジルオキシフェノキシ)プロパン−2−
オール(1.0g,3.9mmol)、ペンタアセチルグルコース
(2.0g,5.1mmol)をジクロロエタン20mlに溶解させ、ト
リフルオロメンタンスルホン酸トリメチルシリル(0.9m
l,5.1mmol) を加え、室温にて1時間攪拌した。その
後、反応液を飽和重曹水、蒸留水にて洗浄し、減圧濃縮
した。残渣をシリカゲルカラムにて分離精製し、1−
(4−ベンジルオキシフェノキシ)−2−(2,3,
4,6−テトラ−O−アセチル−β−D−グルコピラノ
シルオキシ)プロパン(1.4g,収率60%)を得た。 融点 105.2〜117.5 °C
Synthesis Example 2 1- (4-benzyloxyphenoxy) -2- (2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyloxy) propane 1- (4-benzyl Oxyphenoxy) propane-2-
All (1.0 g, 3.9 mmol), pentaacetyl glucose
(2.0 g, 5.1 mmol) was dissolved in 20 ml of dichloroethane, and trimethylsilyl trifluoromenthanesulfonate (0.9 m
(1, 5.1 mmol) was added, and the mixture was stirred at room temperature for 1 hour. Then, the reaction solution was washed with saturated aqueous sodium hydrogen carbonate and distilled water, and concentrated under reduced pressure. The residue is separated and purified with a silica gel column, 1-
(4-benzyloxyphenoxy) -2- (2,3,
4,6-Tetra-O-acetyl-β-D-glucopyranosyloxy) propane (1.4 g, yield 60%) was obtained. Melting point 105.2-117.5 ° C

【0017】合成例3 1−(4−ベンジルオキシフ
ェノキシ)−2−β−D−グルコピラノシルオキシプロ
パン 1−(4−ベンジルオキシフェノキシ)−2−(2,
3,4,6−テトラ−O−アセチル−β−D−グルコピ
ラノシルオキシ)プロパン(1.2g,2.1mmol)を10%ナト
リウムメチラートメタノール溶液60mlに溶解させ、60°
Cにて1時間反応させた。反応液を酸性樹脂を用いて中
和し、減圧濃縮させ1−(4−ベンジルオキシフェノキ
シ)−2−β−D−グルコピラノシルオキシプロパン
(0.8g,収率94%)を得た。
Synthesis Example 3 1- (4-benzyloxyphenoxy) -2-β-D-glucopyranosyloxypropane 1- (4-benzyloxyphenoxy) -2- (2,2
3,4,6-Tetra-O-acetyl-β-D-glucopyranosyloxy) propane (1.2 g, 2.1 mmol) was dissolved in 60 ml of a 10% sodium methylate methanol solution and the mixture was heated to 60 °.
Reaction was carried out at C for 1 hour. The reaction solution was neutralized with an acidic resin and concentrated under reduced pressure to give 1- (4-benzyloxyphenoxy) -2-β-D-glucopyranosyloxypropane.
(0.8 g, yield 94%) was obtained.

【0018】合成例4 2−β−D−グルコピラノシ
ルオキシ−1−(4−ヒドロキシフェノキシ)プロパン 1−(4−ベンジルオキシフェノキシ)−2−β−D−
グルコピラノシルオキシプロパン(4.4g,10.4mmol)をメ
タノール130ml に溶解させ、10%パラジウム炭素を触媒
として、水素雰囲気下で3時間脱ベンジル化反応を行っ
た。触媒を濾別後、反応液を減圧濃縮させ、シリカゲル
カラムにて分離精製し、2−β−D−グルコピラノシル
オキシ−1−(4−ヒドロキシフェノキシ)プロパン
(3.0g,収率86%)を得た。1 H−NMR(DMSO−d6,TMS,ppm) δ1.21〜1.25(m,3H,−C3 ) δ2.91〜2.98(m,1H,グルコース由来) δ3.02〜3.19(m,3H,−CO−) δ3.41〜3.48(m,1H,グルコース由来) δ3.63〜4.11(m,4H,−C2 O−,グル
コース由来) δ4.26〜4.38(m,2H,グルコース由来) δ4.69〜4.85(m,3H,グルコース由来) δ6.63〜6.79(m,4H,ベンゼン環由来) δ8.79,8.82(s,1H,フェノール性水酸基
由来)13 C−NMR(DMSO−d6,TMS,ppm) δ17.2,18.7(−3 ) δ71.8,71.9,72.3,72.4(−HO
−,−2 O−) δ61.1,70.1,73.4,73.6,76.
8,101.6,102.2(グルコース由来) δ115.5,115.6,151.2,151.3
(ベンゼン環由来) 元素分析値 C15228 として 計算値(%) C:62.85 ,H:6.71 実測値(%) C:62.84 ,H:6.72
Synthesis Example 4 2-β-D-Glucopyranosyloxy-1- (4-hydroxyphenoxy) propane 1- (4-benzyloxyphenoxy) -2-β-D-
Glucopyranosyloxypropane (4.4 g, 10.4 mmol) was dissolved in 130 ml of methanol, and the debenzylation reaction was carried out for 3 hours in a hydrogen atmosphere using 10% palladium carbon as a catalyst. After the catalyst was filtered off, the reaction solution was concentrated under reduced pressure, separated and purified by a silica gel column, and 2-β-D-glucopyranosyloxy-1- (4-hydroxyphenoxy) propane.
(3.0 g, yield 86%) was obtained. 1 H-NMR (DMSO-d 6, TMS, ppm) δ1.21 to 1.25 (m, 3H, —C H 3 ) δ 2.91 to 2.98 (m, 1H, derived from glucose) δ 3.02 3.19 (m, 3H, -C H O-) δ3.41~3.48 (m, 1H, derived glucose) δ3.63~4.11 (m, 4H, -C H 2 O-, derived glucose ) Δ 4.26 to 4.38 (m, 2H, derived from glucose) δ 4.69 to 4.85 (m, 3H, derived from glucose) δ 6.63 to 6.79 (m, 4H, derived from benzene ring) δ 8.79 , 8.82 (s, 1H, derived from phenolic hydroxyl group) 13 C-NMR (DMSO-d 6, TMS, ppm) δ17.2, 18.7 ( -C H 3 ) δ71.8, 71.9, 72. .3, 72.4 ( -C HO
-, - C H 2 O-) δ61.1,70.1,73.4,73.6,76.
8,101.6,102.2 (derived from glucose) δ115.5, 115.6, 151.2, 151.3
(Derived from benzene ring) Elemental analysis value Calculated value as C 15 H 22 O 8 (%) C: 62.85, H: 6.71 Measured value (%) C: 62.84, H: 6.72

【0019】合成例5 1−(4−ベンジルオキシフ
ェノキシ)−6−ヘキサノール ハイドロキノンベンジルエーテル(25g,126mmol) に水
250ml 、水酸化ナトリウム(5g,126mmol)を加え、反応
液を120 °Cに保ち溶解させた。6−クロロ−1−ヘキ
サノール(25ml,190mmol)を滴下し、滴下終了後、120
°Cのまま20時間攪拌した。反応液を室温まで冷却する
と生成物が析出してくるので、析出物を濾別し、ベンゼ
ン−ヘキサン混合溶媒で再結晶し、1−(4−ベンジル
オキシフェノキシ)−6−ヘキサノール(23.7g,収率
63%)を得た。 融点 96.3〜97.4°C
Synthesis Example 5 1- (4-benzyloxyphenoxy) -6-hexanol hydroquinone benzyl ether (25 g, 126 mmol) in water
250 ml and sodium hydroxide (5 g, 126 mmol) were added, and the reaction solution was kept at 120 ° C and dissolved. 6-Chloro-1-hexanol (25 ml, 190 mmol) was added dropwise, and after completion of the addition, 120
The mixture was stirred at 20 ° C for 20 hours. When the reaction solution was cooled to room temperature, a product started to precipitate, so the precipitate was filtered off and recrystallized with a mixed solvent of benzene and hexane to give 1- (4-benzyloxyphenoxy) -6-hexanol (23.7 g, yield
63%). Melting point 96.3-97.4 ° C

【0020】合成例6 1−(4−ベンジルオキシフ
ェノキシ)−6−β−D−グルコピラノシルオキシヘキ
サン 1−(4−ベンジルオキシフェノキシ)−6−ヘキサノ
ール(8.1g,27.3mmol)、ペンタアセチルグルコース(11
g,27.3mmol)の混合物にジブチルセルソルブ8mlを加
え、減圧下(6mmHg)、80°Cで溶解させた。りんモリ
ブデン酸(80mg)を加えて減圧下(6mmHg)、80°Cで1
時間反応させた。反応液を酢酸エチルで希釈し、飽和重
曹水、蒸留水にて洗浄し、減圧濃縮した。残渣を10%ナ
トリウムメチラートメタノール溶液60mlに溶解させ、60
°Cにて1時間反応させた。反応液を酸性樹脂を用いて
中和し、減圧濃縮させ1−(4−ベンジルオキシフェノ
キシ)−6−β−D−グルコピラノシルオキシヘキサン
(6.6g,収率50%)を得た。 融点 135.3〜137.6 °C
Synthesis Example 6 1- (4-benzyloxyphenoxy) -6-β-D-glucopyranosyloxyhexane 1- (4-benzyloxyphenoxy) -6-hexanol (8.1 g, 27.3 mmol), penta Acetyl glucose (11
g, 27.3 mmol) was added with 8 ml of dibutyl cellosolve and dissolved at 80 ° C under reduced pressure (6 mmHg). Phosphomolybdic acid (80 mg) was added and the pressure was reduced to 1 mm at 80 ° C (6 mmHg).
Reacted for hours. The reaction mixture was diluted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate and distilled water, and concentrated under reduced pressure. The residue was dissolved in 60 ml of 10% sodium methylate methanol solution,
The reaction was carried out at ° C for 1 hour. The reaction solution was neutralized with an acidic resin and concentrated under reduced pressure to give 1- (4-benzyloxyphenoxy) -6-β-D-glucopyranosyloxyhexane.
(6.6 g, yield 50%) was obtained. Melting point 135.3-137.6 ° C

【0021】合成例7 6−β−D−グルコピラノシ
ルオキシ−1−(4−ヒドロキシフェノキシ)ヘキサン 1−(4−ベンジルオキシフェノキシ)−6−β−D−
グルコピラノシルオキシヘキサン(2.6g,5.1mmol)をメ
タノール50mlに溶解させ、10%パラジウム炭素を触媒と
して、水素雰囲気下で3時間脱ベンジル化反応を行っ
た。反応液を減圧濃縮させ、クロロホルム−メタノール
から再結晶し、6−β−D−グルコピラノシルオキシ−
1−(4−ヒドロキシフェノキシ)ヘキサン(2.0g,収
率98%)を得た。 融点 118.6〜119.5 °C1 H−NMR(DMSO−d6,TMS,ppm) δ1.38,1.54,1.66(m,total8H,−C
2 −) δ2.95(ddd,1H,グルコース由来) δ3.02〜3.29(m,3H,グルコース由来) δ3.44(m,2H,−C2 O−) δ3.67(ddd,1H,グルコース由来) δ3.76(ddd,1H,グルコース由来) δ3.84(t,2H,−C2 O−) δ4.11(d,1H,グルコース由来) δ4.37(dd,1H,グルコース由来) δ4.78,4.80,4.84(eachd,3H,グル
コース由来) δ6.66,6.72(eachd,4H,ベンゼン環由
来) δ8.78(s,1H,フェノール性水酸基由来)13 C−NMR(DMSO−d6,TMS,ppm) δ25.2,25.3,28.7,29.2(−2
−) δ67.9,68.4(−2 O−) δ61.1,70.1,73.4,76.7,76.
8,102.8(グルコース由来) δ115.4,115.6,151.0,151.5
(ベンゼン環由来) 元素分析値 C18288 として 計算値(%) C:58.05 ,H:7.58 実測値(%) C:58.03 ,H:7.58
Synthesis Example 7 6-β-D-Glucopyranosyloxy-1- (4-hydroxyphenoxy) hexane 1- (4-benzyloxyphenoxy) -6-β-D-
Glucopyranosyloxyhexane (2.6 g, 5.1 mmol) was dissolved in 50 ml of methanol, and the debenzylation reaction was carried out for 3 hours in a hydrogen atmosphere using 10% palladium carbon as a catalyst. The reaction solution was concentrated under reduced pressure and recrystallized from chloroform-methanol to give 6-β-D-glucopyranosyloxy-
1- (4-hydroxyphenoxy) hexane (2.0 g, yield 98%) was obtained. Melting point 118.6 to 119.5 ° C 1 H-NMR (DMSO-d 6, TMS, ppm) δ 1.38, 1.54, 1.66 (m, total 8 H, -C
H 2 −) δ2.95 (ddd, 1H, derived from glucose) δ3.02 to 3.29 (derived from m, 3H, glucose) δ 3.44 (m, 2H, —CH 2 O—) δ 3.67 (ddd) , 1H, glucose derived) δ3.76 (ddd, 1H, glucose derived) δ3.84 (t, 2H, —CH 2 O—) δ 4.11 (d, 1H, glucose derived) δ 4.37 (dd, 1H , Glucose derived) δ4.78, 4.80, 4.84 (eachd, 3H, glucose derived) δ6.66, 6.72 (eachd, 4H, derived from benzene ring) δ8.78 (s, 1H, phenolic hydroxyl group derived) 13 C-NMR (DMSO- d 6, TMS, ppm) δ25.2,25.3,28.7,29.2 (- C H 2
−) Δ67.9,68.4 ( −C H 2 O−) δ61.1,70.1,73.4,76.7,76.
8,102.8 (from glucose) δ115.4, 115.6, 151.0, 151.5
(Derived from benzene ring) Elemental analysis value Calculated value as C 18 H 28 O 8 (%) C: 58.05, H: 7.58 Measured value (%) C: 58.03, H: 7.58

【0022】次に、本発明の効果試験方法および評価方
法について説明する。
Next, the effect test method and evaluation method of the present invention will be described.

【0023】(1)美白効果試験試験方法 夏期の太陽光に4時間(1日2時間で2日間)晒された
被験者50名の上腕内側部皮膚を対象として太陽光に晒さ
れた日の5日後より各試料を朝夕1回ずつ8週間塗布し
た。パネルを1群10名に分けて、5群とし下記に示す処
方で試験を行った。
(1) Whitening effect test Test method 50 subjects exposed to the sunlight in the summer for 4 hours (2 hours a day for 2 days) 5 skins exposed to the sunlight From the day after, each sample was applied once in the morning and evening for 8 weeks. The panel was divided into 10 groups per group and divided into 5 groups, and the test was conducted according to the following formulation.

【0024】実施例1〜2,比較例1,2の試料 (アルコール相) 重量% 95%エチルアルコール 25.0 ポリオキシエチレン(25モル)硬化ヒマシ油エーテル 2.0 酸化防止剤・防腐剤 適量 香料 適量 薬剤(表1記載) 1.0 (水相) グリセリン 5.0 ヘキサメタリン酸ナトリウム 適量 イオン交換水 残余 (製法)水相、アルコール相を調製後可溶化する。Samples of Examples 1 to 2 and Comparative Examples 1 and 2 (alcohol phase) wt% 95% ethyl alcohol 25.0 polyoxyethylene (25 mol) hydrogenated castor oil ether 2.0 antioxidant / preservative proper amount perfume proper amount drug ( Table 1) 1.0 (Aqueous phase) Glycerin 5.0 Sodium hexametaphosphate Suitable amount Ion-exchanged water Residual (Production method) The aqueous phase and alcohol phase are prepared and solubilized.

【0025】(評価方法)使用後の淡色化効果を下記の
判定基準に基づいて判定した。 (判定) ◎:被験者のうち著効および有効の示す割合が80%以
上の場合 ○:被験者のうち著効および有効の示す割合が50〜8
0%の場合 △:被験者のうち著効および有効の示す割合が30〜5
0%の場合 ×:被験者のうち著効および有効の示す割合が30%以
下の場合
(Evaluation method) The lightening effect after use was judged based on the following judgment criteria. (Judgment) ⊚: When the rate of marked efficacy and efficacy among the subjects is 80% or more ◯: The rate of marked efficacy and efficacy among the subjects is 50 to 8
In the case of 0% Δ: The ratio of markedly effective and effective in the subjects is 30 to 5
0% ×: When the ratio of markedly effective or effective in subjects is 30% or less

【0026】[0026]

【表1】 [Table 1]

【0027】表1より明らかな様に、太陽光に晒された
後の効果は比較例に比べて実施例の方が過剰のメラニン
色素の沈着を防ぎ、色黒になることを予防することが認
められた。
As is clear from Table 1, the effect after exposure to sunlight is that in Examples, as compared with Comparative Examples, excessive deposition of melanin pigment can be prevented and darkening can be prevented. Admitted.

【0028】[0028]

【発明の効果】本発明に係るハイドロキノンヒドロキシ
アルキルエーテルの配糖体は皮膚美白効果に優れた新規
な化合物である。
The glycoside of hydroquinone hydroxyalkyl ether according to the present invention is a novel compound having an excellent skin whitening effect.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 加来 留美子 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Rumiko Kaku 1050 Shinba-cho, Kohoku-ku, Yokohama-shi, Kanagawa Stock company Shiseido Daiichi Research Center

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】下記一般式化1で表されるハイドロキノン
ヒドロキシアルキルエーテル配糖体。 【化1】
1. A hydroquinone hydroxyalkyl ether glycoside represented by the following general formula 1. [Chemical 1]
【請求項2】ハイドロキノンヒドロキシアルキルエーテ
ル配糖体が、下記一般式化2で表されるハイドロキノン
ヒドロキシアルキルエーテル配糖体であることを特徴と
する請求項1記載のハイドロキノンヒドロキシアルキル
エーテル配糖体。 【化2】
2. A hydroquinone hydroxyalkyl ether glycoside according to claim 1, wherein the hydroquinone hydroxyalkyl ether glycoside is a hydroquinone hydroxyalkyl ether glycoside represented by the following general formula 2. [Chemical 2]
【請求項3】ハイドロキノンヒドロキシアルキルエーテ
ル配糖体が、下記一般式化3で表されるハイドロキノン
ヒドロキシアルキルエーテル配糖体であることを特徴と
する請求項1記載のハイドロキノンヒドロキシアルキル
エーテル配糖体。 【化3】
3. The hydroquinone hydroxyalkyl ether glycoside according to claim 1, wherein the hydroquinone hydroxyalkyl ether glycoside is a hydroquinone hydroxyalkyl ether glycoside represented by the following general formula 3. [Chemical 3]
JP11046794A 1994-04-26 1994-04-26 Hydroquinonehydroxyalkyl ether glycoside Withdrawn JPH07291989A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11046794A JPH07291989A (en) 1994-04-26 1994-04-26 Hydroquinonehydroxyalkyl ether glycoside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11046794A JPH07291989A (en) 1994-04-26 1994-04-26 Hydroquinonehydroxyalkyl ether glycoside

Publications (1)

Publication Number Publication Date
JPH07291989A true JPH07291989A (en) 1995-11-07

Family

ID=14536454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11046794A Withdrawn JPH07291989A (en) 1994-04-26 1994-04-26 Hydroquinonehydroxyalkyl ether glycoside

Country Status (1)

Country Link
JP (1) JPH07291989A (en)

Similar Documents

Publication Publication Date Title
CH675067A5 (en)
CZ100896A3 (en) Water-soluble retinoids
KR100226142B1 (en) Benzophenone derivative, ultraviolet absorbent and external preparation for skin
WO2014092166A1 (en) Tyrosinase activity inhibitor and whitening agent
JPH07291989A (en) Hydroquinonehydroxyalkyl ether glycoside
JP3340928B2 (en) Melanin production inhibitor and whitening cosmetic
JP2000319116A (en) Stabilized gallic acid derivative and external preparation composition containing the same
JP3611164B2 (en) Moisturizer, skin remedy, and skin external preparation
JPH0580449B2 (en)
JP3034057B2 (en) Sugar-cinnamic acid derivatives and UV absorbers
JP2003201264A (en) Hinokitiol derivative and skin care preparation and hair cosmetic containing the same
JP2005082506A (en) Isopropylmethylphenol glycoside
NZ251707A (en) Retinoic acid sugar esters, the sugar having at least one sulphate group; pharmaceuticals and cosmetics
JP3014401B2 (en) Retinoic acid ester of D-desosamine, its preparation, human or veterinary medicine and cosmetic composition
JPH05255376A (en) 5-hydroxy-7-@(3754/24)6"-p-coumaroylglucosyl) flavonol derivative and skin external preparation containing the same
JP3989103B2 (en) Novel flavan derivative, method for producing the same, and cosmetics containing the derivative as an active ingredient
JPH07121854B2 (en) Topical skin
JP3340930B2 (en) Melanin production inhibitor and whitening cosmetic
JPH09241128A (en) Agent for inhibiting activity of tyrosinase
JPH10175820A (en) Suppressant for melanogenesis and beautifying and whitening cosmetic
JP2971915B2 (en) Skin external preparation and whitening agent
JP3144715B2 (en) Styryl ketone derivative, ultraviolet absorber using the same, and external preparation for skin containing the same
JP2000095641A (en) Bleaching preparation
WO2011126098A1 (en) External skin preparation
JP2923358B2 (en) Glycerin cinnamate adduct, UV absorber and external preparation for skin

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20010703